Remove 2024 Remove Article Remove Patent Remove Patent Law
article thumbnail

Examining Upcoming Changes to the Implementing Regulations of the Chinese Patent Law

IP Watchdog

Recently, amendments to the Implementing Regulations of the Chinese Patent Law were issued and will take effect from January 20, 2024. The Regulations align with the revisions made to the Patent Law in 2020 and provide further guidance.

article thumbnail

Highlights of Revised Regulations for Implementing Patent Law of China

JD Supra Law

On December 11, 2023, the State Council of the People’s Republic of China announced its decision to amend the Implementing Regulations of the Patent Law of the People’s Republic of China (the “2023 Regulations”), marking the first update in over 13 years since the last amendment in 2010. By: Sheppard Mullin Richter & Hampton LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

[Guest post]: The proportionality test in European patent law

The IPKat

Injunctions are all the rage in contemporary patent law. This week marks the publication of a book by the IPKat’s Dutch friend and former GuestKat Léon Dijkman on the hotly contested notion of the proportionality test in European patent law, accessible for free here. Oh, how times have changed.

article thumbnail

Discussing Stern’s “Myth of Nonrivalry” for Patent Law

Patently-O

’ This quote from Professor James Stern’s new article introduces the conventional view that ideas and information are nonrivalrous, in contrast to the rivalrous nature of tangible goods. But Stern’s new article bucks the conventional wisdom and instead argues that the nonrivalry of IP is a myth. 1163 (2024).

article thumbnail

New Era of China Patent Law

LexBlog IP

This change represents a considerable shift in the intellectual property law landscape within the country, aiming to promote an environment of genuine innovation and integrity. Improper Transfer: Transferring or acquiring patent application rights for improper purposes.

article thumbnail

Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2024)

JD Supra Law

the Federal Circuit reminds us that most verities in patent law are not eternal and frequently subject to case-by-case interpretation, in this case the purported verity being that reciting the indefinite article ("a") in a patent claim is construed to mean "one or more.". Teva Pharmaceuticals USA, Inc.

article thumbnail

Federal Circuit Overrules Rosen-Durling Test for Design Patent Obviousness

Patently-O

by Dennis Crouch In a highly anticipated en banc decision, the Federal Circuit has overruled the longstanding Rosen-Durling test for assessing obviousness of design patents. May 21, 2024) (en banc). Rejecting the argument that KSR did not implicate design patent obviousness, the court reasoned that 35 U.S.C. § GM Global Tech.